Wesco International Executive Plans $550K Stock Sale on NYSE

Form 144 Notice of Proposed Sale filed by Wesco International (NYSE: WCC) indicates a planned sale of 3,106 shares of common stock with an aggregate market value of $550,192 through UBS Financial Services.

Rhea-AI Filing Summary

Form 144 Notice of Proposed Sale filed by Wesco International (NYSE: WCC) indicates a planned sale of 3,106 shares of common stock with an aggregate market value of $550,192 through UBS Financial Services. The sale is scheduled for June 18, 2025.

The shares were acquired through multiple vesting events in early 2025:

• 2,159 shares from PSU vesting on February 13, 2025
• 264 shares from RSU vesting on February 16, 2025
• 363 shares from RSU vesting on February 17, 2025
• 320 shares from RSU vesting on March 1, 2025

The filing indicates no securities were sold by the reporting person during the past 3 months. The total shares outstanding for Wesco International are reported as 48,803,682.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many WCC shares are being sold according to the Form 144 filing from June 2025?

According to the Form 144 filing, 3,106 shares of WCC common stock are proposed to be sold through UBS Financial Services Inc, with an aggregate market value of $550,192.

What is the source of WCC shares being sold in this Form 144?

The shares being sold came from multiple vesting events in early 2025: 2,159 shares from PSU (Performance Stock Unit) vesting on 02/13/2025, 264 shares from RSU vesting on 02/16/2025, 363 shares from RSU vesting on 02/17/2025, and 320 shares from RSU vesting on 03/01/2025.

What was the total number of WCC shares outstanding as reported in the June 2025 Form 144?

According to the Form 144 filing, WESCO International Inc. (WCC) had 48,803,682 shares outstanding at the time of the filing.

When is the planned sale date for the WCC shares reported in this Form 144?

The Form 144 indicates an approximate date of sale of June 18, 2025 for the proposed transaction.

Did the WCC insider report any other stock sales in the three months prior to this Form 144?

No, the Form 144 filing indicates 'Nothing to Report' in the section regarding securities sold during the past 3 months by the person for whose account the securities are to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2025 - 04:43 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001514429
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	WESCO International, Inc.
SEC File Number	001-14989
Address of Issuer	225 West Station Square Drive Suite 700 Pittsburgh PENNSYLVANIA 15219
Phone	4124542200
Name of Person for Whose Account the Securities are To Be Sold	Christine Wolf
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3106	550192	48803682	06/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2025	PSU Vesting	Issuer			2159	06/18/2025	NA
Common	02/16/2025	RSU Vesting	Issuer			264	06/18/2025	NA
Common	02/17/2025	RSU Vesting	Issuer			363	06/18/2025	NA
Common	03/01/2025	RSU Vesting	Issuer			320	06/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/JOSEPH CASSIDY, as a duly authorized representative of UBS Financial Services Inc, as attorney-in-fact for Christine Wolf
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)